GOLDMAN SACHS GROUP INC - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 241 filers reported holding ARENA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$93,285,000
+9.9%
1,003,716
-29.6%
0.02%
+5.6%
Q3 2021$84,871,000
+33.5%
1,425,210
+52.9%
0.02%
+28.6%
Q2 2021$63,575,000
-15.1%
932,176
-13.6%
0.01%
-26.3%
Q1 2021$74,875,000
-27.5%
1,079,046
-19.8%
0.02%
-26.9%
Q4 2020$103,328,000
+51.6%
1,344,884
+47.6%
0.03%
+36.8%
Q3 2020$68,152,000
+5.2%
911,237
-11.4%
0.02%0.0%
Q2 2020$64,768,000
+214.0%
1,028,869
+109.5%
0.02%
+171.4%
Q1 2020$20,630,000
-12.7%
491,181
-5.6%
0.01%
+16.7%
Q4 2019$23,632,000
+14.8%
520,311
+15.7%
0.01%0.0%
Q3 2019$20,580,000
-30.3%
449,640
-10.7%
0.01%
-33.3%
Q2 2019$29,527,000
+70.1%
503,618
+30.0%
0.01%
+80.0%
Q1 2019$17,363,000
-5.7%
387,310
-18.0%
0.01%
-16.7%
Q4 2018$18,407,000
+15.8%
472,583
+36.9%
0.01%
+50.0%
Q3 2018$15,891,000
-47.9%
345,299
-50.6%
0.00%
-55.6%
Q2 2018$30,478,000
+172.3%
699,041
+146.7%
0.01%
+200.0%
Q1 2018$11,191,000
-18.5%
283,327
-29.9%
0.00%
-25.0%
Q4 2017$13,733,000
+44.0%
404,264
+8.1%
0.00%
+100.0%
Q3 2017$9,535,000
+232.8%
373,923
+120.2%
0.00%
+100.0%
Q2 2017$2,865,000169,8050.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 4,190,000$321,918,0005.54%
Prosight Management, LP 145,700$11,194,0005.17%
Integral Health Asset Management, LLC 200,000$15,366,0004.57%
Copernicus Capital Management, LLC 3,740$287,0004.47%
GREAT POINT PARTNERS LLC 345,120$26,516,0004.31%
Asymmetry Capital Management, L.P. 101,245$7,779,0003.55%
First Light Asset Management, LLC 321,967$24,737,0001.83%
DAFNA Capital Management LLC 76,815$5,902,0001.76%
SECTORAL ASSET MANAGEMENT INC 320,059$24,590,0001.73%
Nicholas Investment Partners, LP 276,633$21,254,0001.64%
View complete list of ARENA PHARMACEUTICALS INC shareholders